
IMARI 2027, returns to Las Begas, January 27-29, 2027. Spectacular program. Abstract deadline August 19 Imari.org

Fan of bugs, resistance genes and salsa dancing Editor in Chief, Antimicrobial Agents and Chemotherapy;

IMARI 2027, returns to Las Begas, January 27-29, 2027. Spectacular program. Abstract deadline August 19 Imari.org

Antibiotic discovery is becoming an important test case for how AI can help science move from pattern recognition to useful biological design. I’m grateful to join @ASMicrobiology’s Editors in Conversation hosted by @SuperBugDoc to discuss AI, antimicrobials, infectious diseases, and the path from discovery to the clinic. A central challenge is not only finding new molecules, but learning how to design, optimize, validate, and translate them. Thank you for the invitation. youtube.com/watch?v=-2fmexU9…

An enriching experience to talk about AMR at the "Editors in Conversation" podcast in India with Prof. Anuradha Chowdhary (@UnivofDelhi) and hosted by Prof. Cesar A. Arias @SuperBugDoc Link: youtu.be/G1KtS6MSjHs?si=3nSF… @ASMicrobiology

Countdown to IMARI 2026, Pre-meeting workshop : Microbiomes as Reservoirs, Catalysts, and Solutions for AMR. Outstanding Speakers (Drs Derick Crook, Cesar De La Fuente, Ashley Earl, Mary Hayden and Michael Woodworth. @IDSAInfo @ASMicrobiology imari.org/

The draft for the 2026 IDSA/ESCMID clinical practice guidelines on 𝘚. 𝘢𝘶𝘳𝘦𝘶𝘴 bacteraemia is now available for public consultation. Get your copy of the manuscript and submit your feedback before 15 December 2025. ow.ly/aJmE50XwVYb

Determining minimum inhibitory concentrations (MICs) is essential for evaluating antimicrobial efficacy. How to optimize the process? This #AACJournal study tests reducing broth microdilution assay volumes w/o compromising MIC accuracy. Get the results: asm.social/2Fy

Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations | Antimicrobial Agents and Chemotherapy (pmc.ncbi.nlm.nih.gov/article…) @SuperBugDoc @ASMicrobiology

IMARI 2026New Antimicrobial Agents Session featuring that are in or entering clinical development. Deadline: December 1, 2025, by 2:00 p.m. ET Notification: December 17, Eligibility Requirements at IMARI.org

High-risk clonal expansion of IMP-producing Enterobacter cloacae complex in regional Japanese healthcare settings | Antimicrobial Agents and Chemotherapy (journals.asm.org/doi/10.1128…) @SuperBugDoc @ASMicrobiology

New issue #AACJournal now out incluidng a minireview of Achromobacter infections, Targeting CARD9 with Small-Molecule Therapeutics, safety of omadacycline in patients with hepatic impairment and much more... @ASMicrobiology @ARLGnetwork aac.asm.org/content/64/11?et…

Deadline for abstract submission @ASMicrobiology @IDSAInfo #IMARI2026 is tomorrow October 1.. Amazing program already in place.. Two outstanding pre-meeting workshops on Pk/PD and Genomics/Microbiome and AMR imari.org/

Abstract deadline for the @ASMicrobiology and @IDSAInfo IMARI 2026 (Interdisciplinary Meeting on Antimicrobial Resistance & Innovation) in Las Vegas, NV is October 1 Registration now OPEN!! @asm_tmc @ARLGnetwork imari.org/

How does Pseudomonas aeruginosa colistin resistance evolve in biofilms? Researchers shine a light on this question in #AACJournal, uncovering similarities and differences in the dynamics of colistin resistance under biofilm and planktonic growth. asm.social/2AW

@SuperBugDoc 🙌🏼
Multidrug-resistant enterococcal infections continue to be a major clinical challenge! 🆕💫Mini Review #AAC Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections #IDXposts journals.asm.org/doi/10.1128…

In the latest episode of Editors in Conversation, we discuss the raise of measles, cliniucal manifestations and mitigation measure with truly outstanding experts in the field @ASMicrobiology @asm_tmc asm.org/podcasts/editors-in-…

Journal reviewers are the core of our scientific mission. #AACJournal celebrates our top reviewers and would be eternally grateful for their contributions @ASMicrobiology